Thanks to a £2.7m (€3.9m) access fund from the UK's National
Biomanufacturing Centre (NBC), biotech firm Onyvax has hired
contract manufacturer organisation (CMO) Eden Biodesign to supply
it with clinical current good manufacturing...
Researchers have been working on a better laboratory method of
detecting ovarian cancer, which is set to improve on routine
screening that is currently available to women by improving
sensitivity to detect the cancer in its earliest...
Genentech has announced that studies of Avastin in
platinum-refractory ovarian cancer patients have been discontinued
due to patients developing a serious bowel problem.
Researchers in the US have found that blocking the COX-1, not COX-2
enzyme, might lead the way to prevent and treat the most common and
fatal form of ovarian cancer.
Morphotek has announced the Food and Drug Administration (FDA) has
accepted its New Drug Application for a humanised monoclonal
antibody, intended for the treatment of advanced ovarian cancer.